Tag Archives: atherosclerotic cardiovascular disease

April, 2017

October, 2016

October, 2015

  • 12 October

    Lilly Discontinues Development of its Experimental Cholesterol Drug

    INDIANAPOLIS, Oct. 12, 2015 /PRNewswire/ — Eli Lilly and Company and the ACCELERATE study’s academic leadership have accepted the recommendation of the independent data monitoring committee to terminate the Phase 3 trial of the investigational medicine evacetrapib, due to insufficient efficacy. Lilly will discontinue development of evacetrapib for the treatment of …